Month: January 2021

Thank you so much Drs. Nguyen and Do for your kind invitation to participate in …

Thank you so much Drs. Nguyen and Do for your kind invitation to participate in 2020 Sonoma Eye – Third Session on January 30 2020! Please join us at https://t.co/GAdGJ5Y1Br https://t.co/mGrUaE5t8j Source by Thomas Ciulla, MD, MBA Return to main website.

Just published: Even in common disorders such as diabetic macular edema, macular…

Just published: Even in common disorders such as diabetic macular edema, macular anatomy, often used for treatment decisions & clinical trial endpoints, has limited correlation to visual acuity. #eyes #retina #diabetes #clinicalresearch #biotech #medicine https://t.co/mVTtQ4N1N1 Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published: Precision medicine is predicated on genetic…


RT @ThomasCiullaMD: Just published: Precision medicine is predicated on genetic testing. However, barriers of cost, complexity, and unfam…


Source by Thomas Ciulla, MD, MBA

Return to main website.

Just published: Precision medicine is predicated on genetic testing. However, …

Just published: Precision medicine is predicated on genetic testing. However, barriers of cost, complexity, and unfamiliarity with genetic testing illustrate unmet need. Educational efforts are underway. #eyes #retina #gene #genetics #genetherapy https://t.co/IAI8Lh5bi7 Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just co-authored this paper on integrin inhibition, a potent…

RT @ThomasCiullaMD: Just co-authored this paper on integrin inhibition, a potentially important pathway for treatment of common causes of v… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @PharmacDaily: Clearside Biomedical Announces First Patients Enrolled in Phas…


RT @PharmacDaily: Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspen…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Just published-With clinical trials from small molecules to …

RT @ThomasCiullaMD: Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #ma… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: I have great fun & satisfaction mentoring @IU_Health reside…

RT @ThomasCiullaMD: I have great fun & satisfaction mentoring @IU_Health residents interested in #research. Congrats to this fantastic IU… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published…Understanding the #genetic basis for this c…


RT @ThomasCiullaMD: Just published…Understanding the #genetic basis for this common cause of #vision loss will facilitate early detection…


Source by Thomas Ciulla, MD, MBA

Return to main website.

Just published-With clinical trials from small molecules to #genetherapy to vira…

Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #macular edema to #AMD to #diabeticretinopathy to choroidal melanoma, an understanding of #suprachoroidal drug delivery becomes essential… https://t.co/4qIjnVZ9RP Source by Thomas Ciulla, MD, MBA Return to main website.